Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hongshu Guan is active.

Publication


Featured researches published by Hongshu Guan.


Arthritis & Rheumatism | 2015

Racial/Ethnic Variation in All‐Cause Mortality Among United States Medicaid Recipients With Systemic Lupus Erythematosus: A Hispanic and Asian Paradox

José A. Gómez-Puerta; Medha Barbhaiya; Hongshu Guan; Candace H. Feldman; Graciela S. Alarcón; Karen H. Costenbader

The incidence of systemic lupus erythematosus (SLE) is disproportionately high in nonwhite patients compared with white patients. However, variation in mortality according to race/ethnicity has not been well studied. The aim of this study was to examine all‐cause mortality according to race/ethnicity among SLE patients enrolled in Medicaid.


Arthritis Care and Research | 2015

Medication Nonadherence Is Associated With Increased Subsequent Acute Care Utilization Among Medicaid Beneficiaries With Systemic Lupus Erythematosus

Candace H. Feldman; Jinoos Yazdany; Hongshu Guan; Daniel H. Solomon; Karen H. Costenbader

We examined whether nonadherence to hydroxychloroquine (HCQ) or immunosuppressive medications (ISMs) was associated with higher subsequent acute care utilization among Medicaid beneficiaries with systemic lupus erythematosus (SLE).


Arthritis Care and Research | 2015

Racial and Ethnic Differences in Mortality and Cardiovascular Events Among Patients With End-Stage Renal Disease Due to Lupus Nephritis

José A. Gómez-Puerta; Candace H. Feldman; Graciela S. Alarcón; Hongshu Guan; Wolfgang C. Winkelmayer; Karen H. Costenbader

To identify racial and ethnic differences in mortality and cardiovascular (CV) risk among patients with end‐stage renal disease (ESRD) due to lupus nephritis (LN).


Lupus | 2015

Specific systemic lupus erythematosus disease manifestations in the six months prior to conception are associated with similar disease manifestations during pregnancy

Sara Tedeschi; Elena Massarotti; Hongshu Guan; Alexander Fine; Bonnie L. Bermas; Karen H. Costenbader

Past studies have focused on aggregate lupus disease activity during pregnancy and have produced conflicting results. Our study evaluated lupus activity based on involvement of five specific organ systems during the six months prior to conception and during pregnancy. We assessed 147 pregnancies among 113 women followed at Brigham and Women’s Lupus Center, 1990–2013. Organ-specific activity included hematologic disorder, nephritis, skin disease, arthritis, and serositis. We hypothesized that the presence of organ-specific activity six months prior to conception would increase the risk for that same type of activity during pregnancy. Our study population was 68% white; 100% had a positive ANA and 30% had a history of nephritis. Among women with organ-specific lupus activity during the six months before conception, the crude odds for the same type of activity during pregnancy was 7.7- to 32.5-fold higher compared to women without that type of activity immediately before conception. An adjusted logistic regression model also indicated significantly higher odds of organ-specific activity during pregnancy if that type of activity were present six months before conception. Approaching lupus based on specific organ systems may be a useful way for women and their physicians to consider the potential risk for disease activity during pregnancy.


Lupus | 2016

Disease activity and transition outcomes in a childhood-onset systemic lupus erythematosus cohort.

Mary Beth Son; Y Sergeyenko; Hongshu Guan; Karen H. Costenbader

Objective The chronicity and severity of childhood-onset systemic lupus erythematosus (cSLE) necessitate effective transition from pediatric to adult providers. We studied transition outcomes in a cSLE cohort. Methods We identified patients at an adult lupus clinic diagnosed with SLE ≤ 18 years who had been followed by a pediatric rheumatologist. Data extracted from the first three years in adult care (“post-transition period”) included: sociodemographics, depression, anxiety, SLE manifestations, SLE Disease Activity Index (SLEDAI) and Systemic Lupus International Collaborating Clinics/ACR Damage Index for SLE (SLICC) scores, non-adherence, and gaps in care (no appointments in the recommended time frame). Multivariable logistic regression analyses for predictors of: (1) time between pediatric and adult providers, (2) gaps in care, (3) unscheduled utilization (emergency department visits and admissions) (4) depression and/or anxiety were performed, as was a multivariable Poisson regression analysis for number of missed appointments. Results In 50 patients, SLEDAI scores were stable (mean 5.7 ± 5.0 at start vs. 4.7 ± 4.8 at year 3, p = 0.2), but SLICC scores increased (0.46 ± 0.84, vs. 0.78 ± 1.25, p = 0.01). Depression and anxiety increased significantly (10% vs. 26%, p = 0.02). Mean time from last pediatric to first adult provider visit was almost nine months (253 ± 392 days). Nearly 75% of patients had ≥ 1 gap in care. White race, low education level and non-adherence were significantly associated with missed appointments. Conclusion Despite moderate disease activity in this cSLE transition cohort, prolonged time between pediatric and adult providers and gaps in care in the post-transition period occurred. Anxiety and depression were frequently reported. Future work should identify methods to improve transition.


Arthritis & Rheumatism | 2017

Comparative Rates of Serious Infections Among Patients With Systemic Lupus Erythematosus Receiving Immunosuppressive Medications.

Candace H. Feldman; Francisco M. Marty; Wolfgang C. Winkelmayer; Hongshu Guan; Jessica M. Franklin; Daniel H. Solomon; Karen H. Costenbader; Seoyoung C. Kim

While infection burden is high among patients with systemic lupus erythematosus (SLE), there is uncertainty about whether infection rates differ by immunosuppressive drug regimens. We undertook this study to compare infection rates among SLE patients newly initiating immunosuppressive therapy with mycophenolate mofetil (MMF), azathioprine (AZA), or cyclophosphamide (CYC).


Arthritis Care and Research | 2017

Serious Infection Rates Among Children With Systemic Lupus Erythematosus Enrolled in Medicaid

Linda T. Hiraki; Candace H. Feldman; Francisco M. Marty; Wolfgang C. Winkelmayer; Hongshu Guan; Karen H. Costenbader

To investigate the nationwide prevalence and incidence of serious infections among children with systemic lupus erythematosus (SLE) enrolled in Medicaid, the US health insurance program for low‐income patients.


Arthritis & Rheumatism | 2017

Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

Medha Barbhaiya; Candace H. Feldman; Hongshu Guan; José A. Gómez-Puerta; Michael A. Fischer; Daniel H. Solomon; Brendan M. Everett; Karen H. Costenbader

Systemic lupus erythematosus (SLE) is more prevalent and results in more severe outcomes among blacks, Asians, and Hispanics than among whites. Cardiovascular disease (CVD) is the leading cause of death among SLE patients. We undertook this study to examine racial/ethnic variations in risk of CVD events among SLE patients.


Arthritis & Rheumatism | 2018

Sex Differences in Health Care Utilization, End-Stage Renal Disease, and Mortality Among Medicaid Beneficiaries With Incident Lupus Nephritis

Candace H. Feldman; Anna Broder; Hongshu Guan; Jinoos Yazdany; Karen H. Costenbader

While systemic lupus erythematosus and lupus nephritis (LN) disproportionately affect females, previous studies suggest that males may experience poorer outcomes. We undertook this study to investigate sex differences in health care utilization, end‐stage renal disease (ESRD), and mortality among patients with LN receiving Medicaid, public insurance for low‐income individuals.


Arthritis Care and Research | 2018

Lipid Testing and Statin Prescription among Medicaid Recipients with Systemic Lupus Erythematosus, Diabetes Mellitus and the General Medicaid Population

Sarah K. Chen; Medha Barbhaiya; Michael A. Fischer; Hongshu Guan; Tzu-Chieh Lin; Candace H. Feldman; Brendan M. Everett; Karen H. Costenbader

Cardiovascular disease (CVD) risks in systemic lupus erythematosus (SLE) are similar to those in diabetes mellitus (DM). We investigated whether the numbers of lipid tests and statin prescriptions in patients with SLE are comparable with those in patients with DM and those in individuals without either disease.

Collaboration


Dive into the Hongshu Guan's collaboration.

Top Co-Authors

Avatar

Karen H. Costenbader

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Candace H. Feldman

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Medha Barbhaiya

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Daniel H. Solomon

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Brendan M. Everett

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Michael A. Fischer

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Alexander Fine

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Bonnie L. Bermas

Brigham and Women's Hospital

View shared research outputs
Top Co-Authors

Avatar

Jinoos Yazdany

University of California

View shared research outputs
Researchain Logo
Decentralizing Knowledge